The Audiologist Informer

Today's news and insights for busy audiologists
Published Mar 07, 2023

Easy to unsubscribe at any time. Your e-mail address is safe — here's our privacy policy.

Lenire Tinnitus Treatment Device Granted De Novo Approval by FDA

Neuromod Devices Ltd. announced today that the US Food and Drug Administration (FDA) has granted De Novo approval to Lenire—the first bimodal neuromodulation device of its kind to be approved by the FDA for the treatment of tinnitus.

hearingtracker․com
Comparing Hearing Aid Outcomes in Adults Using Over-the-Counter (OTC) and Hearing Care Professional (HCP) Service Delivery Models

A survey using the HearingTracker and OTC Lexie hearing aid databases yielded responses to the IOI-HA outcome tool from 406 conventional and 250 OTC hearing aid users. No significant difference in overall hearing aid outcomes between HCP and OTC users (including app-based fitting, acclimatization, remote support, behavioral incentivization, and payment options) was evident, although HCP clients reported significantly longer hours of daily use.

pubs․asha․org
Hearing Health Matters SPECIAL EDITION: World Hearing Day 2023

World Hearing Day 2023 highlighted the importance of integrating ear and hearing care within primary care. In this podcast Blaise Delfina talks with Dr. Abram Bailey and Dr. Steve Taddei of HearingTracker; Dr. Douglas L. Beck Au.D. of Cognivue, Inc; Dr. Mark Campbell-Foster of Redux; Gael Hannan and Shari Eberts, authors of the book 'Hear & Beyond'; Dr. Dave Fabry of Starkey Hearing, and Dr. Amit Gosalia of AudBoss.

pdcn․co
Getting Real: An Interview with Oticon President Gary Rosenblum about Oticon Real Hearing Aids

HearingTracker interviews Oticon President Gary Rosenblum about the company's newest flagship hearing aid, Oticon Real, as well as BrainHearing, DNN, and the Polaris R platform that drives technology in the new device.

hearingtracker․com

News

Audio/Video

Research